Is AI a Tool or a Taskmaster? architectmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from architectmagazine.com Daily Mail and Mail on Sunday newspapers.
Armed with qualifications from Oxford and Harvard, a UJ doctorate in law and awards and accolades from respected institutions across the globe, Prof Letlhokwa George Mpedi has published no less than 38 peer-reviewed articles, eight (co)-authored books, more than 60 chapters in peer-reviewed boo.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Curative Biotechnology, Inc. Announces Trading Symbol Change to “CUBT”
Curative Biotechnology, Inc. April 29, 2021 GMT
Kapil Bharti, Ph.D. and Dimiter Dimitrov, Ph.D. Join Scientific and Clinical Advisory Board
Boca Raton, FL, April 29, 2021 (GLOBE NEWSWIRE) Curative Biotechnology, Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the Company’s trading symbol change from “CTYX” to “CUBT”. As previously announced, the Company had changed its corporate name to Curative Biotechnology, Inc. to better represent its mission to discover and develop therapeutics for patients who have few, if any, effective treatments for rare diseases.
Curative Biotechnology, Inc. Announces Ticker Symbol Change to CUBT on OTC Markets
iCrowd Newswire
Company Appoints Kapil Bharti, Ph.D., and Dimiter Dimitrov, Ph.D. to Scientific and Clinical Advisory Board
Boca Raton, FL
iCrowd Newswire/ April 29, 2021 /
Curative Biotechnology, Inc. (OTC: CUBT) a development-stage biomedical company focused on novel therapies for rare diseases, announced today the Company s trading symbol change from CTYX to CUBT . As previously announced, the Company had changed its corporate name to Curative Biotechnology, Inc. to better represent its mission to discover and develop therapeutics for patients who have few, if any, effective treatments for rare diseases.
Share this article
BOCA RATON, Fla., April 29, 2021 /PRNewswire/
Curative Biotechnology, Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the Company s trading symbol change from CTYX to CUBT . As previously announced, the Company had changed its corporate name to Curative Biotechnology, Inc. to better represent its mission to discover and develop therapeutics for patients who have few, if any, effective treatments for rare diseases.
Curative Biotechnology Inc. Chairman and President Paul Michaels said, This name and symbol change are reflective of our total remaking of this company and our mission to create treatments or cures for unmet medical needs for patients around the world.